NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/16/2023
Back to search
Official data from USPTO
STREPTAMER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
STREPTAMER
ST13
US500000078135112Class
1, 5, 42
Filing
78135112
Registration
2769226
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
12/16/2023
Trademark type
Word
Nice classes
1, 5, 42
Filing date
06/12/2002
Registration date
09/30/2003
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/16/2023
Last transaction
12/16/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
1
Owner type
99
Owner location
Gottingen, DE
Examiner
KON, ELISSA GARBER
Law office
M70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
IBA GmbH
Representatives
Michael A. Whittaker Acuity Law Group
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
chemicals used in biopharmaceutical industry and science for the isolation of body cells and cells of the immune system of mammalsfor scientificmedical or laboratory research; diagnostic reagents for scientific or research use; analytic kits comprising streptavidin or streptavidin muteins carrying a fluorescent and/or magnetic label and/or recombinant MHC I or MHC II molecules fused to an affinity labelbinding to such labeled streptavidin or streptavidin muteinsused for the isolation of T cells under maintenance of their authentic properties
Class 5
pharmaceuticalmedical and veterinary preparationspolypeptides and proteins produced by genetic engineeringincluding fusion proteinsbody cells and cells of the immune system of mammalsall used for the treatment of graft rejections and/'or viral infections and/or cancer by providing functionalantigen specific T cells for adoptive transferfor the monitoring of the functional T cell status after vaccinations; medical diagnostic reagents
Class 42
scientific and industrial research in the fields of biochemistrymedical diagnostics and pharmaceuticals; biochemical and pharmaceutical laboratory services featuring the synthesis of recombinant polypeptides and proteinscultivator and purification of cells and cells of the immune system of mammals including human cells
Publications
History of USPTO decisions and trademark events.
29 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
12/16/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/16/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/16/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
06/22/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/30/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/30/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/30/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/30/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/30/2013
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
09/26/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
09/26/2013
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/11/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/11/2013
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
03/17/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/16/2010
ES8R
TEAS SECTION 8 RECEIVED
03/12/2010
CFIT
CASE FILE IN TICRS
07/18/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
09/30/2003
PUBO
PUBLISHED FOR OPPOSITION
07/08/2003
NPUB
NOTICE OF PUBLICATION
06/18/2003
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/18/2003
CNEA
EXAMINERS AMENDMENT MAILED
03/18/2003
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
03/18/2003
1.BD
Sec. 1(B) CLAIM DELETED
02/10/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/10/2003
PAPER RECEIVED
02/10/2003
CNRT
NON-FINAL ACTION MAILED
10/15/2002
DOCK
ASSIGNED TO EXAMINER
10/07/2002
Continuous trademark protection
Get notified about every new filing that threatens STREPTAMER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.